Congress Asset Management CO Supernus Pharmaceuticals, Inc. Transaction History

Congress Asset Management CO

$14.3 Billion
Q3 2024

A detailed history of Congress Asset Management CO transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Congress Asset Management CO holds 8,994 shares of SUPN stock, worth $325,762. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,994

Previous 9,081 0.96%

Holding current value

$325,762

Previous $242,000 15.7%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$25.77 - $35.16 $2,241 - $3,058	-87 Reduced 0.96%	8,994 $280,000
Q2 2024 Aug 02, 2024	SELL	$25.99 - $33.85 $26.6 Million - $34.6 Million	-1,023,060 Reduced 99.12%	9,081 $242,000
Q1 2024 Apr 11, 2024	BUY	$27.11 - $35.17 $3.02 Million - $3.92 Million	111,333 Added 12.09%	1,032,141 $35.2 Million
Q4 2023 Mar 04, 2024	BUY	$22.72 - $29.68 $82,791 - $108,153	3,644 Added 0.4%	920,808 $26.6 Million
Q3 2023 Nov 01, 2023	BUY	$27.57 - $32.91 $4.06 Million - $4.84 Million	147,105 Added 19.1%	917,164 $25.3 Million
Q2 2023 Jul 27, 2023	BUY	$29.91 - $38.73 $6.26 Million - $8.11 Million	209,422 Added 37.35%	770,059 $23.1 Million
Q1 2023 Apr 21, 2023	BUY	$34.93 - $42.03 $1.88 Million - $2.26 Million	53,846 Added 10.62%	560,637 $20.3 Million
Q4 2022 Jan 18, 2023	SELL	$31.09 - $37.88 $20,892 - $25,455	-672 Reduced 0.13%	506,791 $0
Q3 2022 Nov 08, 2022	BUY	$28.79 - $35.41 $746,265 - $917,862	25,921 Added 5.38%	507,463 $17.2 Million
Q2 2022 Aug 02, 2022	BUY	$25.33 - $34.25 $441,780 - $597,354	17,441 Added 3.76%	481,542 $13.9 Million
Q1 2022 Apr 20, 2022	BUY	$28.51 - $32.9 $1.94 Million - $2.24 Million	67,996 Added 17.17%	464,101 $15 Million
Q4 2021 Jan 28, 2022	BUY	$26.37 - $34.22 $2.17 Million - $2.81 Million	82,250 Added 26.21%	396,105 $11.6 Million
Q3 2021 Nov 08, 2021	BUY	$23.54 - $31.39 $449,001 - $598,732	19,074 Added 6.47%	313,855 $8.37 Million
Q2 2021 Aug 05, 2021	BUY	$26.72 - $33.19 $7.88 Million - $9.78 Million	294,781 New	294,781 $9.08 Million

Others Institutions Holding SUPN

# of Institutions

282

Shares Held

60.9M

Call Options Held

27.7K

Put Options Held

11.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.94B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Congress Asset Management CO with notifications on news.

Account

Congress Asset Management CO Supernus Pharmaceuticals, Inc. Transaction History